Navigation Links
Biomet Hip Replacement Lawsuits: Bernstein Liebhard LLP Comments on Ongoing Biomet M2a Magnum Hip Replacement Studies
Date:6/5/2013

New York, NY (PRWEB) June 05, 2013

As Biomet hip replacement lawsuit claims continue to move forward, the nationwide law firm of Bernstein Liebhard LLP notes that Biomet Inc. is conducting two studies to assess the safety of metal-on-metal hips, including the Biomet M2a Magnum Hip Replacement System. According to a notice posted November 6, 2012 on clinicaltrials.gov, the company is currently enrolling participants in an observational study investigating adverse local tissue reactions in recipients of metal-on-metal hip implants. The study, which is being conducted in compliance with the U.S. Food & Drug Administration’s (FDA) 2011 post-market surveillance order directing metal-on-metal hip replacement manufacturers to conduct safety studies of their products, is expected to be completed in December 2014.*

According to a second notice posted on clinicaltrials.gov that was updated on March 6th, Biomet has been conducting a study in Japan since 2009, the purpose of which is to investigate metal ion release and renal function in M2a Magnum hip patients. The study, which is no longer recruiting participants, is expected to be completed by December 2021, though final data collection for the study’s primary outcome measure is expected to conclude this December.**

“We continue to hear from patients who have allegedly suffered serious complications due to metal-on-metal hip implants, and are representing a number of clients in Biomet hip lawsuits involving the M2a Magnum hip. Post-market surveillance data is desperately needed to fully understand the risks associated with these devices,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free Biomet hip replacement lawsuit evaluations to individuals allegedly injured by the Biomet M2a hip.

Biomet Hip Lawsuits
Dozens of Biomet hip replacement lawsuits are currently pending in a multidistrict litigation underway in U.S. District Court, Northern District of Indiana. All of the lawsuits filed in the proceeding allege the metal-on-metal design of the Biomet M2a Magnum can generate high levels of metal ions, leading to metallosis in the surrounding tissue and early failure of the device. Bernstein Liebhard LLP is actively filing Biomet hip lawsuits in this litigation. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)

The FDA is continuing to investigate the safety of metal-on-metal hip implant devices like the Biomet M2a Magnum hip. According to a communication issued by the agency on January 17th, the FDA has proposed an order requiring manufacturers of metal-on-metal total hip replacement systems to submit premarket approval (PMA) applications, which would make them ineligible for 510(k) clearance. This process allowed all-metal hips, like the Biomet M2a Magnum, to come to market without first undergoing human clinical trials. The FDA has also recommended that doctors consider metal ion testing for all-metal hip replacement patients who are experiencing symptoms of a failing implant, including pain, swelling, loosening of the implant, or change in the ability to walk.***

Victims of metal-on-metal hip implant side effects allegedly associated with the Biomet M2a hip, including metallosis and premature device failure, may be entitled to compensation for medical bills, lost wages, and pain and suffering. A wealth of information about Biomet hip lawsuits is available at Bernstein Liebhard’s website. For additional information, please contact one of our attorneys today by calling 800-511-5092.

*clinicaltrials.gov/ct2/show/NCT01750606?term=NCT01750606&rank=1
**clinicaltrials.gov/ct2/show/NCT01010763?term=Biomet+M2a+Japan&rank=1
**fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/biomet-hip-lawsuit/biomet-m2a-magnum-hip/prweb10805024.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. MinuteHound Announces Software Update Featuring Safe and Effective Biometric Recognition
2. Biomet Hip Lawsuit News: Bernstein Liebhard LLP Notes Latest Developments in Federal Litigation for Biomet Hip Replacement Lawsuits
3. PharmaSmart® and Kinney Drugs Partner up to Unveil Newest Advancement in Pharmacy-Based Biometric Screening and Mobile Interoperability
4. Biomet Hip Lawsuit: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Biomet Hip Replacement Litigation
5. Biomet Hip Replacement Lawsuits: Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Biomet Hip Litigation
6. MinuteHound Releases Time Clock Software Featuring Secure Biometric Technology for Business Applications
7. MinuteHound Annouces Top 5 Reasons Businesses Increasingly Switching To Biometrics
8. Law Firm Issues Biomet Hip Infographic Warning Consumers About the Dangers of Biomet Hip Implants
9. MinuteHound News: Top Three Ways To Save Money With Biometric Time and Attendance Solutions
10. US Drug Watchdog Now Urges All Zimmer Stryker, Biomet, Wright and DePuy All Metal Hip Implant Recipients to Get A Blood Test For A Failure-Don't Get Left Holding the Bag
11. US Drug Watchdog Now Urges All Zimmer, Stryker, Biomet, Wright and DePuy Metal Hip Implant Recipients to Get Blood Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... IN (PRWEB) , ... February 10, 2016 , ... ... benefits advisory organization, welcomes S.S. Nesbitt as the latest addition to its growing ... has seven other locations throughout the Southeast, from Orlando to Huntsville and in ...
(Date:2/10/2016)... ... ... Armune BioScience signed a definitive agreement with ARCpoint Labs ... the country. Launched in April of 2015, Apifiny is the only cancer specific, non-PSA ... volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact ... , Pioneering book "Better with Age: The Ultimate Guide to Brain Training" by award-winning ... improve memory. The book’s publication date is March 16, 2016. A free review ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined the award-winning ... to physicians. The integration will enable Allscripts users to post open appointments to ... mobile app. , The partnership gives Everseat substantial added power to help Allscripts ...
(Date:2/10/2016)... ... ... Workrite Ergonomics this week announced the launch of the Conform Monitor Arm Series, ... was to develop a product from the ground up that would provide the most ... Hulsey, Product Manager for Workrite Ergonomics. “The Conform series features a wide variety ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... -- LexisNexis® Risk Solutions, a leading provider of data, ... LexisNexis Provider Performance Monitor , a clinical ... the quality and efficiency of provider networks through ... measuring provider performance through Provider Performance Monitor, payers ... improve the patient experience and reduce costs, as ...
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 ... biopharmaceutical company developing novel, clinical-stage therapies for sickle cell ... an underwritten public offering of 29,090,910 units at a ... unit consists of one share of the Company,s common ... the Company,s common stock at an exercise price of ...
(Date:2/10/2016)... ALSP, Inc. announced that it has appointed Col.(Retired) Dallas ... preparation for its move into clinical trials with its lead ... are pleased to welcome Dallas Hack onto the ... of such practical knowledge and far-reaching experience in Traumatic Brain ... broad experience and success as a clinician and researcher in ...
Breaking Medicine Technology: